Digital Lung Acoustics for Better Insight
Continuously measure patients’ lung sounds from anywhere, anytime
As Featured In
See the Full Respiratory Picture
Stethoscope auscultation is key in identifying abnormal sounds to diagnose and monitor respiratory diseases, yet it has been limited to in-person, episodic visits. The RESP Biosensor is the first FDA-cleared device to provide a continuous, passive measurement of patients’ lung sounds from hospital to home.
For Clinicians
Enhance surveillance and management of patients with chronic respiratory diseases
For Researchers
Strengthen evidence and insight into subject treatment response in clinical trials
How It Works
An end-to-end solution for remote monitoring of lung health
RESP® Biosensor
Patient receives system and adheres device to their chest with a provided adhesive
Strados™ Mobile App
Patient starts device recording via mobile app, with lung sound data securely transferred to the app
Strados™ Cloud
Cloud securely stores data where lung sounds are identified by either algorithms or trained annotators
750K+
Lung Sounds Captured
20M+
Breaths Captured
4
35
2
1
The Award-Winning Technology Revolutionizing Lung Health
Privacy & Security
Designed for Daily Life
Low-burden, discreet design aids patient comfort while accurately collecting data in the real world.
Global Experience
Used in patients and subjects in four continents and 35 languages.
Beyond Cough
Extended capabilities beyond cough frequency include intensity, bouts, lung sounds and vitals* for a fuller understanding of patient health.
Clinically Validated Accuracy
*Measurement not FDA-cleared
FAQ
Strados Labs Frequently Asked Questions
News & Resources
Strados Labs Collaborates with Beth Israel Deaconess Medical Center for Innovative Study in Pulmonary Edema
The study will evaluate continuous lung sound monitoring for the early detection of pulmonary edema and prevention of complications in critically ill ICU patients. Philadelphia, PA, February 20, 2025 — Strados Labs, a medical technology company focused on improving...
Why the Tegaderm™ Adhesive is a Trusted Solution for the RESP® Biosensor
In research studies and healthcare settings, minimizing patient burden is essential for reliable data collection with wearables and devices. At Strados Labs, we understand the importance of these factors with the RESP® Biosensor, which is designed to continuously...
Cough as an Endpoint in IPF Trials: Why it Matters
Increased importance has been placed in recent years on the ability of idiopathic pulmonary fibrosis (IPF) treatments to impact how patients feel and function, beyond survival (Raghu, et al., 2024). In IPF, one of the most burdensome symptoms impacting how patients...
Let's Talk
Speak to one of our respiratory experts to learn more